Increase access to hepatitis C (HCV) testing and care in drug services- a toolkit
Submitted by Edie
- 2 August 2021
People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains low among people who inject drugs and effective approaches to promote testing as the first element of a cascade of care are particularly needed.
EMCDDA has put together a toolkit to increase access to testing and care in drug services.
The toolkit includes:
- Assessing the needs: a step-by-step guide
- Hepatitis C: new models of care for drug services
- Knowledge questionnaire and other hepatitis materials
- Further resources to support policymaking and practice
Links
